関連する実験動画
Updated: Sep 16, 2025

09:28
Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
Published on: November 17, 2018
11.7K
マルチアジュバントパーソナルネオアンチゲンワクチンは,メラノーマに対する強力な免疫を生成する
Eryn Blass1, Derin B Keskin2, Chloe R Tu3
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA.
Cell
|July 11, 2025
まとめ
この研究では,パーソナライズされたネオアンチゲンワクチンと複数の免疫補助剤を組み合わせることで,メラノーマ患者のT細胞反応が向上することが示されています. 多面的なアプローチは ワクチンの免疫性を高め より良い結果のために 腫瘍の微小環境を再構成します
科学分野:
- 腫瘍学
- 免疫学
- ワクチン開発
背景:
- パーソナライズされたネオアンチゲンワクチンは 癌の治療には有望ですが 強化された免疫性が必要です
- ワクチンの有効性を最大化するために有効なT細胞プリミングと抗原の可用性は極めて重要です.
- 強力な抗腫瘍免疫反応を誘発するために,現在の戦略はしばしば改善する必要があります.
研究 の 目的:
- メラノーマ患者におけるマルチ補助剤戦略と組み合わせた新型合成長ペプチドワクチンの免疫性を評価する.
- この組み合わせ療法がT細胞の反応と腫瘍の微小環境に与える影響を評価する.
- ネオアンチゲンワクチンの有効性を高めるために,多角的な免疫補助作用の可能性を調査する.
主な方法:
- 10人のメラノーマ患者が個別化されたネオアンチゲンワクチンを接種した.
- ワクチン製剤には,モンタニド,ポリICLC,局所性イピリムマブと全身性ニボルマブが含まれていた.
- T細胞応答,T細胞受容体 (TCR) クローン型,腫瘍免疫細胞現象型を分析した.
主要な成果:
- パーソナライズされたワクチンは,完全にワクチン接種した患者の9/9において,ほとんどのネオエピトープに対して,de novo ex vivo T細胞反応を誘発した.
- CD8+ T細胞のex vivo応答は6/9の患者で観察された.
- ワクチン接種は,PD- 1 阻害のみと比較して,循環および腫瘍内 TCR クローン型を生成しました.
- この研究では,ワクチン接種後の腫瘍内T細胞の再生が示されました.
結論:
- 多角的な免疫補助的アプローチは,個別化されたネオアンチゲン標的ワクチンに対するT細胞の反応を著しく高めることができます.
- この戦略は腫瘍の 免疫微生物環境を再構成し 癌の免疫療法に 有望な可能性を提示します
- パーソナライズされたワクチンを複数の補助剤と組み合わせることは,がんワクチンの免疫性を改善する有効な戦略です.
関連する概念動画
Tumor Immunotherapy
664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664
Cancer Vaccines
517
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
517
Antigens Involved in Adaptive Immunity
690
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
690
Cytotoxic T Cells-mediated Immune Response
2.3K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.3K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K

